Vlad Vitoc

Chief Executive Officer

Vlad Vitoc (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in MAIA Biotechnology, Inc. (MAIA). Across 1 priced purchase filing, the average 21-session return was +3.6% from execution and +2.1% from disclosure (delay-adjusted; derived). The largest single filing was $101K of MAIA (72,700 sh × $1.39, as filed), executed Jun 1.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+3.6%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+2.1%

same 1 filings, from disclosure

Filings, ttm

2 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$201K

shares × price, as filed

Last traded

Sep 14

Filed Sep 15

Median ADV $915K across their filed names

50% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.

Open performance→

Volume by month

Buys $201K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

MAIA

MAIA Biotechnology, Inc. MAIA · 2 buys · 0 sells 2 filings

Recent filings

MAIAPURCHASE MAIA Biotechnology, Inc. View filing → $100K
73,000 sh × $1.37
Exec Sep 14
Filed Sep 15 · 6:33 AM ET MAIAPURCHASE MAIA Biotechnology, Inc. View filing → $101K
72,700 sh × $1.39
Exec Jun 1
Filed Jun 2 · 9:02 AM ET